LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (3)
Qube Research
$19.1M
added
Bank of America
$87.4M
added
BlackRock
$242.3M
added
Top-trader positions in RTO could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Mar 25, 2026
Period ending
Dec 31, 2025
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Dec 31, 2025 | Mar 25, 2026 | Unavailable | - | $6.91B No estimateYear ended Dec 31, 2025 · SEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Jun 2024 | Dec 2024 | Jun 2025 | Dec 2025 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.71B | $2.73B | $4.58B | $3.53B |
| Cost of what it sold | $2.32B | $2.39B | $3.96B | $3.04B |
| Gross profit | $385.0M | $341.0M | $620.0M | $489.5M |
| What it spent | ||||
| Research and development | — | $7.0M | — | — |
| Other operating costs | $64.0M | $106.0M | $205.8M | $1.11B |
| Total operating expenses | $64.0M | $113.0M | $205.8M | $1.11B |
| What was left | ||||
| Operating profit | $321.0M | $228.0M | $414.3M | $489.5M |
| Interest on debt | $96.0M | $96.0M | $126.7M | $132.3M |
| Profit before tax | $253.0M | $152.0M | $294.3M | $173.1M |
| Tax | $57.0M | $41.0M | $70.9M | $47.8M |
| Net profit | $196.0M | $111.0M | $256.2M | $280.6M |
| EBITDA | $601.5M | $513.1M | $859.4M | $761.1M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Broker Tips: Rentokil Initial, Burberry, Vistry, Smiths and Kingfisher
Leans bullishOct 20Rentokil faces US pricing pressure as AI reshapes pest-control market
Leans bearishOct 19Rentokil Initial (LSE:RTO) Could Be 32% Below Fair Value On Half Year Results
NeutralOct 17Rentokil Initial (LSE:RTO) Could Be 32% Below Fair Value On Half Year Results
Leans bullishOct 17Rentokil Initial plc (RTON.MX) latest press releases and corporate news
NeutralOct 16Rentokil Initial rallies Friday, outperforms market
BullishOct 16Rentokil Initial (LON:RTO) Stock Rating Reaffirmed as Buy by Jefferies Financial Group
BullishOct 16UBS Cuts Rentokil Initial PT, Affirms Buy Rating
Leans bullishOct 15